Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from ...
At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...
In the same week, his younger brother Liam achieved something remarkable closer to home by making his debut for Sunderland’s ...
Sanofi is betting $1.53 billion on a novel drug from Sino Biopharmaceutical, securing global rights to a first-in-class JAK/ROCK inhibitor that could play a double role in the French pharma’s ...
Background: Disruption of axonal connections between thalamus and cortex leads to thalamic degeneration in cortical projection area after ischemic stroke. Recent studies have indicated that ...
A large clinical cohort study of adult patients taking JAK inhibitors for atopic dermatitis has found that they have more than twice the risk of developing acne at 6 months than patients taking Th2 ...
AN INVESTIGATIONAL, new ointment targeting the Janus kinase (JAK) pathway has shown promising results for adults with mild-to-moderate atopic dermatitis (AD), offering rapid itch relief and sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results